Remote Monitored Systems continues trials for products

Remote Monitored Systems PLC said Tuesday that its wholly owned subsidiary Pharm 2 Farm Ltd. is continuing trials for two products, and that it is in discussions with potential partners for each product.

The London-listed technology company said that progress on these products has been delayed because of the development of–and focus on–an antiviral mask, and that this has absorbed a significant amount of time.

Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).

There does not appear to be a profile here yet (if this your your plc please get in touch)
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
DirectorsTalk

More articles like this